Article Details

Drug regulator's nod sought for phase-3 study of intranasal Covid vaccine in 5-18 age group

Retrieved on: 2022-09-11 23:56:05

Tags for this article:

Click the tags to see associated articles and topics

Drug regulator's nod sought for phase-3 study of intranasal Covid vaccine in 5-18 age group. View article details on hiswai:

Excerpt

On September 6, the Drugs Controller General of India (DCGI) had approved its intranasal Covid vaccine iNCOVACC for restricted emergency use in those ...

Article found on: www.thehindubusinessline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up